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ABSTRACT 
Two multi-analyte flow-through immunoassay formats for rapid detection of 
mycotoxins in a variety of food matrices (peanut cake, maize and cassava flour) were 
developed and evaluated. The selected food matrices are typical staple foods and 
export products for most low-income communities around the world. The assay 
formats included a gel-based and a membrane-based flow-through assays and were 
based on the principle of indirect ELISA. Using the same immunoreagents, the 
performance characteristic of both assays were compared. To the best of our 
knowledge, this is the first report on such comparison. The gel-based format was 
developed to screen for ochratoxin A, fumonisin B1, deoxynivalenol and zearalenone 
detection at cut-off values of 3 µg kg
-1
, 1250 µg kg
-1
, 1000 µg kg
-1 
and 200 µg kg
-1 
respectively, while the membrane-based format can be used to screen ochratoxin A, 
aflatoxin B1, deoxynivalenol and zearalenone at the following cut−offs, 3 µg kg
-1
, 5 µg 
kg
-1
, 700 µg kg
-1
 and 175 µg kg
-1
 respectively. The applicability of these assay formats 
was demonstrated by evaluating the performance characteristics of both tests through 
performing multiple experiments on different days. Both assays were further evaluated 
by analyzing naturally contaminated samples in the laboratory and also in the field 
under tropical conditions (Cameroon; West Africa). The false negative rate with both 
formats was less than 5 %, which is in good agreement with Commission Decision 
2002/657/EC regarding the performance of analytical methods intended for screening 
purposes.  
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INTRODUCTION 
Mycotoxins are natural, relatively small secondary metabolites, which are produced by 
moulds for example Aspergillus, Fusarium and Penicillium growing on agricultural 
commodities in the field or after harvest [1]. Humans as well as livestock are exposed 
to mycotoxins through the consumption of contaminated food and feed and through 
inhalation of airborne mycotoxins. Mycotoxins are potentially harzardous to both 
humans and domestic animals as they cause a wide range of diseases [2]. Among the 
potentially toxic mycotoxins identified so far, aflatoxins, fumonisins, trichothecenes, 
patulin, ochratoxins, ergot alkaloids and zearalenone (ZEN) continue to receive most 
of the attention as they pose great threat to human and animal health [1]. Selecting a 
suitable method for mycotoxin analysis involves using a suitable sample preparation 
protocol and an efficient separation and detection method. Most of the separation 
methods reported in literature are chromatographic ones while the detection methods 
include ultraviolet (UV) spectroscopy, fluorescence and (tandem) mass spectrometry. 
But also biosensors and immunochemical methods are valuable analytical tools [3]. 
Selecting a suitable method for bio-monitoring of food contaminants such as 
mycotoxins will in many instances greatly depend on the final objective. For instance, 
when large sample series have to be monitored for a group of contaminants, sample 
throughput will be an important criterion since speed is of the essence. In this regard, a 
screening method is preferred. Enzyme linked immunosorbent assay (ELISA) is 
widely accepted as the “gold standard” screening method [4]. As pre-requisite, such 
screening methods should minimize false negative results. On the other hand, when 
samples are suspected to contain one or more undesirable substances, method 
selectivity will no doubt be the main criterion because avoiding false non-compliant 
(positive) is of overriding importance. To add to the ever increasing demand for more 
selective analytical methods, there is also a growing demand to develop multiplex 
screening assays to replace single analyte assays. So far, most multiplex assays are 
mostly chromatographic based confirmatory methods such as high performance liquid 
chromatography (HPLC), capillary electrophoresis (CE) and gas chromatography 
(GC) [2].  
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However, chromatographic methods are not only time consuming but are also 
expensive and require highly skilled personnel for their operation, which limits its 
usage in resource limited laboratories especially in developing countries. For this 
reason, attention has now turned towards the development of “rapid tests” or 
techniques, which make use of simple hand-held equipments for multiplex detection. 
Immunochemical based “rapid tests”, including but not limited to immunoassays have 
been widely used in a variety of fields and applications especially to safeguard the 
primary health and wellbeing of humans. “Rapid tests” devices also referred to as 
point of care (POC) devices, may be considered as simple low cost alternatives to the 
more sophisticated ELISA and liquid chromatography tandem mass spectrometry (LC-
MS/MS) methods [5]. Examples of some immunochemical based rapid POC devices 
reported in literature consist of lateral flow and flow-through test devices. These 
devices are well established diagnostic tools in laboratories worldwide and continue to 
gain more credibility because they are subjected to rigorous intra−laboratory 
validation before they are put on the market. Some POC devices are based on visual 
observation of results to discriminate between compliant and non-compliant samples 
and as such are generally referred to as non-instrumental methods. 
Recently, there has been an upsurge in the number of literature on non-instrumental 
immunochemical methods for mycotoxin detection. Examples of which include lateral 
flow dipstick, flow-through gel-based assay (GBA) and flow−through membrane-
based assay (MBA) [6-11]. The advantages associated with the use of such assay are 
not only limited to the fact that it gives qualitative and or semi-quantitative results in 
less than 30 minutes, but also that analysis can be performed on site. Most of these 
assays were initially designed as single analyte assays but after a period of extensive 
research two analyte GBA and MBA flow-through assays were later developed [10, 
12-18]. There has been the growing demand to further extend the scope of these assays 
to include more than two analytes while maintaining a high degree of sensitivity and 
specificity. Of all the multiplex (two analyte based assays) GBA and MBA reported so 
far for mycotoxin analysis none was developed for screening of food matrices typical 
of low-income communities. Thus, a multiplex assay capable of screening mycotoxins 
in a variety of food matrices would greatly meet the target need (providing cheap and 
reliable analytical methods) of low-income countries and or laboratories where access 
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to analytical hard-ware, financial resources and skilled analytical personnel is limited. 
Most of these low-income communities are not necessarily poor countries but have 
proven in the last decade to be emerging economies with a great potential for 
economic growth. Immunological methods are cost-effective and adaptable to the 
situation in low-income countries [19]. 
In this study, two multiplex non-instrumental immunoassay (the gel-based format and 
membrane-based flow−through) formats were developed for screening of mycotoxins 
in a variety of food matrices (maize, peanuts, peanut cake and cassava flour). 
Although they have been used previously for mycotoxin detection, the two formats 
have not been compared directly. Here, we used the same antibodies to develop and 
optimize both formats and compared their performance on the same sample extracts, 
in assay buffer and using various food matrices. Development of field−portable assays 
are increasing, thus such a comparison should be of wide interest. A new coupling 
support (Sepharose Activated 4B Fast Flow) was used instead of the traditional 
Sepharose Activated 4B. In addition, direct coupling of the anti−mycotoxin antibody 
to the coupling support was also evaluated for the first time. For the membrane-based 
assay, two other membranes types (Biotrace NT and activated PES ultrabind) widely 
used for protein transfer and binding were also evaluated. 
 
The MBA was developed for the detection of aflatoxin B1 (AFB1), ochratoxin A 
(OTA), ZEN and  deoxynivalenol (DON) while the GBA was developed for fumonisin 
B1 (FB1), OTA, ZEN and DON detection. These toxins were selected due to their 
frequent occurrence in these food matrices. The performance characteristics and 
robustness of these assays were compared. Qualitative results obtained with these 
screening assays were compared with results obtained after performing a confirmatory 
test using LC-MS/MS. Both immunochemical assays were also evaluated for their 
robustness under tropical field conditions. 
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Experimental  
Reagents and materials 
CNBr activated Sepharose 4B Fast Flow and CNBr activated Sepharose 4B were 
purchased from GE Healthcare Bio−Science (Uppsala, Sweden). Immunodyne ABC 
membrane (pore size 0.45µm), Biotrace NT (pore size 0.2 µm) and activated PES 
ultrabind (pore size 0.45 µm) were obtained from Pall France (Saint 
Germain−en−Laye, France). Absorbent pads (type AP-080, 20X25 mm) were supplied 
by Advanced Microdevices Pvt (Ambaka Cantt, India). As flow-through device, a 
plastic snap-fit device from Trosley Equipment (Dover, Kent, UK) was used. Grace 
octadecyl (C18) solid phase extraction (SPE) cartridges were obtained from Grace 
Discovery Sciences (Lokeren, Belgium). Bond Elut cartridges (1 and 3 mL) and 
polyethylene frits (1/4 in. and 3/8 in. diameter) were supplied by Varian (Sint-
Katelijne-Waver, Belgium). Water was purified using a Milli-Q Gradient System 
(Millipore, Brussels, Belgium). N, N–dimethylformamide was purchased from Acros 
Organics (Geel, Belgium). Methanol, HPLC-grade was purchased from VWR 
International (Zaventem, Belgium). Proclin 300 (5−chloro−2-methyl−4−isothiazolin-
3-one plus 2-methyl-4-isothiazolin-3-one) was purchased from Supelco (Bellefonte, 
PA, USA) and was added as an antimicrobial preservative to the buffers. Concentrated 
hydrochloric acid (HCl), sodium acetate, sodium chloride, sodium hydrogen 
carbonate, glycine and glycerol were obtained from Merck (Darmstadt, Germany). 
Bovine serum albumin (BSA) and Tween 20 were purchased from Sigma Aldrich 
(Bornem, Belgium). A 0.45 m syringe filter was obtained from Macherey-Nagel 
(Neumann-Neander, Germany). Ultrafree MC centrifugal devices (0.22 µm) of 
Millipore (Millipore, Brussels, Belgium). 
Rabbit anti-mouse immunoglobulin (IgG; protein concentration: 2.7 g/L) was supplied 
by DakoCytomation (Heverlee, Belgium). Monoclonal anti-ZEN antibody was 
prepared at Ghent University, Ghent, Belgium [20]. ZEN−horseradish peroxidase 
(ZEN−HRP) conjugate was prepared as described in Basova et al. [17]. Cross-
reactivity of the ZEN monoclonal antibody was 69% with α-zearalenol, 42% with 
α−zearalanol, 22% with zearalanone and none at all (<1%) with β−zearalenol and 
β−zearalanol. The substrate chromogenic solution used was Colorburst Blue 
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TMB/Peroxide (ALerCHEK, Maine, USA). Monoclonal antibodies against FB1, AFB1 
and OTA were prepared by the Institute for Animal Sciences, Agricultural 
Biotechnology Center, Gödöllö, Hungary. FB1−HRP, AFB1−HRP and OTA−HRP 
conjugates were produced and characterized by the same institute. Monoclonal 
anti−FB1 antibody was an IgG1 (protein content:1 g/L) with kappa light chain and an 
affinity constant of 1.3 × 10
10 
M
−1
 [21]. The anti−OTA antibody was an IgG1 with 
kappa light chains with a 9.3% cross-reaction with ochratoxin B (OTB) but none at all 
with ochratoxin α (OTα), coumarin, 4-hydroxy-coumarin and d,l−phenylalanine. The 
anti−AFB1 antibody was IgG2a with 79% cross-reaction with aflatoxin M1, 33% with 
aflatoxin M2, 76% with aflatoxin B2 (AFB2), 55% with aflatoxin G1 (AFG1), 6% with 
aflatoxin G2 (AFG2). Monoclonal anti−DON antibody (clone 4) and DON-HRP were 
developed at USDA−ARS−NGAUR, Peoria, IL, USA and kindly provided by Dr. 
Chris Maragos. The cross-reactivity of the DON antibody was 429% with 
15−acetyl−DON and <0.5% with nivalenol.  
From a stability point of view mycotoxin-HRP conjugates and anti-mycotoxin 
antibodies  were kept in concentrated form at -20
°
C. Stock solutions were prepared in 
phosphate buffered saline (PBS)−1%glycerol and stored at −20°C. Working solutions 
were made in PBS−1% BSA and used for 3 weeks. PBS (0.01 M, pH 7.4), was used to 
make the wash solution (PBS−Tween 0.05%), the blocking solution (PBS−casein 2%) 
and the assay buffer (PBS−casein 0.1%). DON and AFB1 standards were supplied by 
Sigma Aldrich (Bornem, Belgium). ZEN and OTA were supplied by Enzo 
LifeSciences (Antwerpen, Belgium). FB1 was supplied by Promec Unit (Tyberg, South 
Africa). Stock solutions of DON, OTA and ZEN (1 mg mL
−1
) and working solutions 
(100 μg mL−1) were prepared in methanol and stored at −20°C. Stock solution of 
AFB1 (1 mg mL
−1
) and working solution (10 µg mL
−1
) were prepared in 
dimethylformamide and stored at −20°C. Stock solutions of FB1 (1 mg mL
−1
) were 
prepared in acetonitrile/water (50/50, v/v) and stored at 4 
o
C. All working solutions 
were used for 3 months.  
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Sample preparation and recovery experiments 
The same sample preparation procedure was applied for both the GBA and MBA. One 
gram of blank samples was weighed into two separate extraction tubes (A and B). 
During the entire assay development, two sets of parallel samples were used. Tube A 
(set 1) was spiked to a pre-determined (cut−off) concentration of each of the target 
mycotoxins. Tube B (set 2) was left unspiked (control blank). Extraction solvent (2.5 
mL) which comprised of methanol/water (80/20, v/v) mixture was added to each of 
the tubes. Extraction was performed by vigorous shaking with the hand for 7 min. The 
extract was let to stand for 5 min to allow sedimentation of particulate matter. The 
supernatant was drawn into a syringe for sample clean-up. 
Clean-up of the sample extract was carried out using a custom made sample clean-up 
column. The design of the clean-up column was the same for both the GBA and the 
MBA. The preparation of the clean-up column was as follows: in an empty 3 mL 
Bond Elut Reservoir, a frit was placed at the bottom. Approximately 250 mg of C18 
clean−up sorbent was filled into the clean−up column. A second frit was placed on top 
of the C18 clean−up sorbent. Prior to loading of the sample extract onto the clean−up 
column, 2 mL of PBS solution was used to condition the C18 SPE sorbent. The entire 
sample extract was loaded onto the clean-up column and allowed to flow-through at a 
flow rate of one drop per second without the application of vacuum. Then, 1 mL of the 
cleaned extract was diluted in 3 mL PBS. This diluted extract was drawn into a 
syringe and used for analysis. 
For every recovery experiment, two parallel sets of samples were used. One set was 
spiked to a predetermined concentration prior to the start of the sample preparation 
protocol (begin spike), while another set was spiked after the desired sample treatment 
was performed (end spike). All experiments were performed in triplicate. The ratio of 
the peak area of the begin spike to the peak area of the end spike were used to 
calculate the analyte recovery. 
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Preparation of immunoassay gels (GBA) 
Preparation of the coupled-gel and blocked-gel  
 
Rabbit anti-mouse immunoglobulin was coupled to activated Sepharose 4B Fast-Flow 
to give a coupled-gel. The coupling protocol requires first the activation of the 
Sepharose 4B Fast-Flow powder using acidified water. Coupling was performed as 
follows: Sepharose 4B Fast Flow (0.6 gram results in a final volume of 1.5 mL) was 
brought onto a sintered glass filter and washed with 200 mL of 1 mM HCl (pH 2). 
Rabbit anti−mouse immunoglobulin (500 µL) dissolved in 500 µL of coupling buffer 
(NaHCO3, pH 8.3, containing 0.5 M NaCl) was added to the activated Sepharose gel. 
Using an orbital shaker, the content in the sintered glass filter was swirled for 2 h at 
room temperature. Then, 10 mL of the coupling buffer was used to wash off excess of 
rabbit anti-mouse immunoglobulin. The unreacted active sites on the Sepharose 
activated gel were blocked by adding 15 mL of the blocking buffer (0.2 M glycine, 0.1 
M NaHCO3, pH 8.3 containing 0.5 M NaCl). The coupled gel was then washed with 3 
cycles of low (0.1 M Na acetate, pH 4.0 containing 0.5 M NaCl) and high pH (0.1 M 
NaHCO3, pH 8.3 containing 0.5 M NaCl) solutions. The final gel was reconstituted in 
1.5 mL of PBS buffer and kept at 4
o
C until use. For the preparation of the blocked gel, 
the protocol was the same except for the fact that no rabbit anti−mouse 
immunoglobulin was added during the coupling protocol. 
Direct coupling of the anti-mycotoxin antibodies to the Sepharose 4B Fast Flow 
support was also performed separately for each respective anti-mycotoxin antibody. 
The coupling procedure was similar to that of the blocked gel except for the absence 
of rabbit anti-mouse immunoglobulin. The following anti−mycotoxin antibody 
dilutions and volumes were used for the coupling process (500 µL (1/50 dilution) for 
OTA, 150 µL (1/5000) for DON, 500 µL (1/2000) for FB1 and 600 µL (1/500) for 
ZEN). 
 
Preparation of multiplex GBA column 
 
The preparation of the multiplex assay column consisted of preparing single analyte 
screening gels separately. Four separate single analyte screening gels were prepared. 
The preparation of each single analyte screening gel layer was carried out in a 3 mL 
 11 
 
empty SPE reservoir. The optimized protocol was as follows: a 3/8 inch frit was 
pushed through the inlet to the bottom of an empty Bond Elut SPE reservoir. A 225 
µL portion  of the blocked gel was loaded onto the empty SPE reservoir followed by 
25 µL of the anti-mouse coupled gel (1:10 dilution of the coupled gel). The mixture 
was swirled gently for 2 min to ensure homogeneity of the gel solution. Excess of PBS 
was flushed out. Specific volumes of diluted anti−mycotoxin antibodies for the 
different toxins (50 µL (1/50 dilution) for OTA, 15 µL (1/5000) for DON, 50 µL 
(1/2000) for FB1 and 60 µL (1/500) for ZEN) were added separately into the 
corresponding single analyte gel solutions and allowed for 10 min for coupling. This 
was followed by removal of the excess PBS solution. The respective anti−mycotoxin 
antibodies are now coupled to the Sepharose gel. Uncoupled anti-mycotoxin 
antibodies were removed by washing with 1 mL of the washing solution 
(PBS−0.05%Tween 20). After the preparation of the separate single analyte screening 
gels, each of the gel solutions was in turn brought into a new 3 mL SPE reservoir to 
form the multiplex assay screening column. The thickness of each gel layer was 
estimated at approximately 5 mm with each layer separated from the next by two 3/8 
inch frits (Fig. 1a). Thus, a multiplex screening column for four mycotoxins was 
established. There was no preference in the order of the different screening zones.  
 
Gel-based assay protocol 
 
For every series of analysis, an experiment with a blank sample was performed to 
check the performance of the assay. The diluted cleaned sample extract, drawn into a 
10 mL syringe was loaded onto the multiplex assay column. The sample extract was 
allowed to flow through the multiplex assay column at a flow-rate of about 1 drop 
every five seconds. Excess of unbound mycotoxins was removed by washing the assay 
column with 20 mL of washing solution. Fresh PBS solution (2 mL) was added. 
Dilutions of the respective mycotoxin−HRP conjugates prepared separately 
(FB1−HRP (1/2000), OTA−HRP (1/2000), ZEN−HRP (1/2000) and DON−HRP 
(1/2000)) were pooled and added onto the multiplex assay column. With the help of a 
syringe, the pooled solution of the mycotoxin-HRP conjugates was flowed through the 
multiplex assay column (PBS solution). Excess mycotoxin−HRP conjugates were 
washed off with 15 mL of the washing solution. For colour development, 500 µL of 
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the HRP substrate (Colorburst Blue TMB/Peroxide) was added. The substrate solution 
was split in two parts of 250 µL each prior to addition. One part was introduced 
through the inlet of the assay column while the other part was drawn in through the 
outlet. The colour intensity was visually evaluated after 5 min. The whole procedure 
(not including preparation of coupled and blocked gels) took 30 min and was 
performed at room temperature. 
 
Preparation of immunoassay membranes (MBA) 
Preparation of the Immunodyne ABC membranes 
 
Immunodyne ABC membranes were cut into rectangular shapes of 2 cm x 4.5 cm. 
Four circles with a diameter of 0.3 cm each were marked on the surface of each 
membrane. To ensure that the circles did not overlap, a distance of 0.5 cm was kept 
between each circle. A 1 L portion of undiluted rabbit anti-mouse immunoglobulin 
was spotted within each circle (Fig. 1b). The membranes were dried for 30 min at 
37°C. In order to saturate the remaining covalent sites on the membranes, the 
membranes were soaked in a blocking buffer (PBS−2% casein) for 15 min, followed 
by drying at 37°C for 30 min. A 10 L portion of the respective diluted anti-
mycotoxin-antibody (anti−AFB1 (1/100), anti−OTA (1/500), anti−ZEN (1/10) and 
anti−DON (1/500)) was applied on each of the respective single analyte detection 
spots. The membranes were dried at 37°C for 15 min and immediately stored under 
vacuum in polyethylene bags for 3 days at room temperature. 
Assembly of the MBA plastic cassette 
A simple MBA flow−through device consisted of two components, an Immunodyne 
ABC nylon membrane and absorbent pads, which are enclosed within a plastic 
cassette. The bottom part of the plastic cassette was filled up with absorbent pads (9 
layers of absorbent pads). Then, the prepared assay membrane was placed on the stack 
of absorbent pads. The top part of the plastic cassette was then fitted and held in 
position with a tape. Fig. 1c and 1d show a typical arrangement of a multiplex assay 
cassette. 
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MBA protocol 
Prior to use, the assay membranes were rehydrated by adding dropwise, 500 L of 
assay buffer (PBS−0.1%casein). Assay reagents were then added in sequence onto the 
membrane. Between each step, the reagents were allowed to flow through completely 
aided by the absorbent pads. The diluted sample extract was then added to the 
membranes. Five times 100 L of PBS−0.05%Tween 20 was used to wash-off 
interfering substances. This was followed by the addition of 20 L of the respective 
mycotoxin−HRP conjugates (AFB1−HRP (1/100), OTA−HRP (1/100), ZEN−HRP 
(1/1000) and DON−HRP (1/1000)) onto the corresponding single analyte detection 
zone. The membranes were again washed with 500 L of PBS−0.05%Tween 20 
followed by 5 other washes with 100 L of PBS. A 25 L portion of substrate was 
applied on each spot for both the test and the control immunoassay membranes. The 
colour intensity of the individual spots was visually evaluated after 3-5 min. The 
whole procedure took 30 min and was achieved at room temperature.  
 
Naturally contaminated samples 
 
The samples used in the study were part of a much larger survey carried out in 
Cameroon, West Africa in the month of December, 2010. In total 200 samples of the 
three matrices (maize, peanuts and cassava) were sampled from three of Cameroon’s 
five agroecological regions. At the time of sampling, samples were randomly selected 
and screened with the optimized flow-through assays. All screening experiments were 
performed in the shadow where the average field temperature was 28±1.6°C. Small 
portions of homogenized ground samples were used for the screening experiments. 
 
LC-MS/MS analysis 
A Waters Acquity UPLC system (Waters, Zellik, Belgium) and a Micromass Quattro 
micro triple quadrupole mass spectrometer were used for separation and detection of 
the analytes of interest. The analytical protocol described in Ediage et al. [22], was 
used for the analysis of naturally contaminated samples. The protocol was as follows: 
to a one gram portion of a homogenized sample, internal standards zearalanone (ZAN) 
and deepoxy-deoxynivalenol (DOM) were added at concentrations of 200 μg kg-1 and 
10 μg kg-1 respectively. The sample was extracted with 25 mL of methanol/ethyl 
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acetate/water (70/20/10, v/v/v), during 20 min and centrifuged for 15 min at 3170g. 
The extract was evaporated at 40
o
C under a stream of nitrogen. The residue was 
reconstituted in 5mL of methanol/water (85/15, v/v) to which 10 mL of 
dichloromethane/hexane (30/70, v/v) solution was added and shaken for 10 min. After 
centrifugation at 3200g for 10 min, the dichloromethane/hexane phase was discarded 
while the methanol/water phase was kept for further clean-up. The defatted extract 
(methanol/water phase) was further split into two parts of 2.5 mL each for sample 
enrichment (clean-up). One part (of the split-up extract) was cleaned by passing it 
through a glass fiber filter while the second part was cleaned up using aminopropyl 
(NH2) cartridges, mounted on a vacuum elution manifold. The amino cartridge was 
first conditioned with 5 mL of the reconstitution solvent. After the conditioning step, 
the sample extract was loaded onto the SPE cartridge and the eluate collected in a test 
tube. The reconstitution solvent (1 mL) was used to wash the SPE cartridge with the 
intention of eluting most of the loosely trapped (through weak hydrophobic 
interactions) mycotoxins with the exception of fumonisin and ochratoxin A, both of 
which are strongly retained by the SPE absorbent. Both parts (the NH2 SPE and glass 
fiber filter) of the cleaned extracts were recombined and evaporated under a gentle 
stream of nitrogen. The residue was dissolved in 100 μL of mobile phase consisting of 
methanol/water/acetic acid (57.2/41.8/1, v/v/v) and 5 mM ammonium acetate. 
Ultrafree MC centrifugal devices were used to further filter the resulting solution prior 
to injection into the LC-MS/MS system; this was performed for 15 min at 14000g. 
 
The column used was a 150 mm×2.1 mm i.d., 5 μm, Symmetry C18, with a 10 mm×2.1 
mm i.d. guard column of the same material (Waters, Zellik, Belgium). The injection 
volume was 20 μL. The mobile phase consisted of variable mixtures of mobile phase 
A (water: methanol/acetic acid, 94/5/1 (v/v/v) and 5 mM ammonium acetate) and 
mobile phase B (methanol/water/acetic acid, 97/2/1 (v/v/v) and 5 mM ammonium 
acetate) at a flow rate of 0.3 mL min
-1
 with a gradient elution programme. The mass 
spectrometer was operated in the positive electrospray ionisation (ESI+) mode. 
Capillary voltage was 3.2 kV and nitrogen was used as spray gas. Source and 
desolvation temperatures were set at 150°C and 350°C, respectively. The optimized 
parameters for both the precursor and product ions are as described in Ediage et al. 
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[22]. The method was validated according to Commission Decision 2002/657/EC [23] 
and Commission Regulation (EC) No. 401/2006 [24]. 
Assay Validation 
Performance characteristics for both the GBA and MBA  
In order to provide robust assays to end users, the performance characteristics of any 
analytical method must be defined and properly validated. So far, for qualitative 
analytical (screening) methods, there are no general validation procedures available 
and especially screening methods for mycotoxins in foods. However, according to 
Commission Decision 2002/657/EC, only those analytical techniques for which it can 
be demonstrated in a documented traceable manner that they are validated and have 
false compliant rate of less than 5% at the levels of interest shall be used for screening 
purposes. In case a non-compliant outcome occurs, the result should be verified by a 
complementary method (EC, 2002) [23].  
Validation of immunoassays involves determining a series of analytical performance 
characteristics. The following seven performance characteristics are relevant to 
evaluate (assess) when validating qualitative screening assays for mycotoxin 
determination; cut-off limits, specificity, sensitivity, false positive rate, false negative 
rate, positive predicted value and negative predicted value. The assay cut-off limits 
were determined during validation studies by constructing a response (performance 
characteristic) curve of percentage positives (P(x)) results versus concentration. From 
this curve, the cut-off limits was defined as the analyte concentration which gave 100 
% true positive results. A positive result generated no signal, in this case no coloration. 
On the other hand, a negative test results in an intense blue coloration with no 
difference in color intensity between both test and control. To construct such a 
response curve, a series of blank samples spiked at 8 different concentration levels, in 
10 replicates were used. In total 80 samples of each sample matrix were used. All 
samples were screened with external standards to ascertain if they were blank or not. 
Five of the 8 concentration levels were below a pre-determined assay cut-off limits for 
the different analytes, 2 levels above the pre-determined cut-off limits and one level at 
the pre-determined cut-off limit. The pre-determined cut-off limits were obtained 
during pre-validation studies. The spiked concentration levels were different for each 
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analyte which was based on the maximum limits of each analyte in the different food 
stuffs as laid down by the European Commission Decision. Commission Regulation 
(EC) No 1126/2007 of 28 September 2007 [25] amends Regulation (EC) No 
1881/2006 which sets maximum levels for certain contaminants in food stuff as 
regards Fusarium toxins in maize and maize products [26]. Furthermore, Commission 
Regulation (EC) No 1881/2006 of 19 December 2006, has established maximum 
levels for certain contaminants in food stuff including peanuts and its processed 
products. 
From the performance characteristic curve, the uncertainty region for each analyte was 
also determined. This region is defined as the concentration range within which 
identification (detection) becomes unreliable. For practical reasons, the final analyte 
cut-off limits for the different analytes were obtained using single analyte assays. 
These cut-off limits were later reassessed and adapted with the multi-analyte screening 
assay. 
After having known the final assay cut-off limits, the six other performance 
characteristics (specificity, sensitivity, false positive rate, false negative rate, positive 
predicted value and negative predicted value) were then determined. Parallel blank 
samples (40) of each of the three sample matrices (maize, peanut cake and cassava) 
were used. A set of 20 samples were used as control blanks (n=20 for each analyte) 
while the other set of 20 samples were fortified with the target analyte at the respective 
assay cut-off limits. Control and test experiments were always realized in parallel and 
each result was shown blindly to three other colleagues who visually evaluated the 
results. The following equations were used to calculate the other six performance 
parameters:  sensitivity (Ntrue positive /(Ntrue positive + Nfalse negative) × 100(%)), specificity 
rate (Ntrue negative /(Ntrue negative + Nfalse positive) × 100(%)), false positive rate (Nfalse positive 
/(Ntrue positive + Nfalse positive)× 100(%)), false negative rate (Nfalse negative /(Ntrue negative + Nfalse 
negative) × 100 (%)), positive predictive rate (Ntrue positive /(Ntrue positive + Nfalse positive) × 
100(%)), negative predictive rate (Ntrue negative /(Ntrue negative + N false negative) × 100(%)). 
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Results and discussion 
Optimization of the sample preparation procedure  
Before considering the use of any clean-up procedure, the diluted sample extract 
(diluted 1/3, v/v in PBS) was applied directly on the membrane. This approach, if 
successful would lead to a considerable reduction in the total assay time. However, 
this application led to blocking of the membrane and the gel, seconds after the sample 
extract was applied. Due to this shortcoming, this approach was not further developed. 
This experience demonstrated the need to eliminate smaller particulate matter, hence, 
the need for a sample clean-up procedure. Filtration of the sample extract prior to 
dilution was deemed necessary. This procedure consisted of passing 1.5 mL of the 
sample extract through a 0.45 m syringe filter followed by the addition of 1.5 mL of 
PBS. Recovery experiments were performed along side to assess the percentage of 
each of the mycotoxins trapped by the filter. The results show (Table 1), that only 
small amounts of the analytes were trapped by the filters (DON (3%), OTA (5.4%), 
FB1 (2.5%) and 0% for AFB1 and ZEN, respectively). Adding 1.5 mL of PBS to the 
sample extract resulted in a cloudy and foamy solution. When this solution was 
brought onto the assay membrane, it led to clogging of the membrane. The high ionic 
strength of the PBS solution could probably have caused aggregation of proteins, 
glucose and fatty acids (organic soluble compounds) and hence, the formation of a 
colloidal solution. Colloidal particles can reach diameter of 50 m or more [27], which 
are large enough to block the pores of both the Immunodyne ABC membrane (0.45 
µm).  
A material which can be used to trap these molecules (colloidal particles), is a C18 
sorbent. For this reason a C18 custom-made clean-up column was designed as 
described in the section of sample preparation and recovery experiments. The filtrate 
obtained with the C18 clean-up sorbent was more translucent than the filtrate obtained 
from the other previously described sample treatments. Besides, dilutions of the 
sample extract with PBS did not lead to any cloudy or foamy solution and the entire 
sample extract could easily flow through the membrane. This clearly proved that the 
bigger particles and the molecules responsible for the formation of colloidal particles 
were eliminated during the sample clean-up. Table 1 also shows the percentage of 
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mycotoxins trapped in the custom-made C18 column. The results revealed significant 
binding of OTA and AFB1 to the C18 particles. Although a significant amount of AFB1 
and OTA was lost with the custom made clean-up sorbent, this sample preparation 
procedure was preferred to other previously tested protocols. 
Optimization of the dilution factor for the sample extract 
The efficiency of extraction (recovery) using three different volumes (2.5 mL, 5 mL 
and 10 mL) of extraction solvent methanol/water (80/20, v/v) was evaluated. Recovery 
experiments were performed as described in the section of sample preparation and 
recovery experiments. The LC-MS/MS conditions were the same as described in 
Ediage et al. [22]. As expected, a lower volume will result in a much lower analyte 
recovery and vice versa. The recovery data for the different extraction volumes 
obtained for the respective analyte and matrices evaluated are shown in Table 2. 
Though, a higher analyte recovery was obtained with the 10 mL solution, the 2.5 mL 
extraction volume was preferred because it gave the highest concentration of analyte 
per mL of extraction solvent. This parameter was considered important since the 
sample extract was expected to undergo further dilution prior to analysis.  
Dilution of the sample extract after clean-up and prior to analysis was necessary in 
order to minimize the content of organic solvent in the final sample extract. For this 
reason, four different dilution ratios (1/1, 1/3, 1/5 and 1/10, v/v) were evaluated. A 1/3 
(v/v) dilution ratio of the sample extract in PBS gave the best optimum results. A 
dilution ratio (1/5 and 1/10, v/v) resulted in high analyte cut−offs limits while a low 
dilution ratio (1/1, v/v) generated no analytical signal. This could be due to the high 
proportion of organic solvent which might have contributed to a possible denaturation 
of the antibodies. Furthermore, preliminary experiments, revealed that 4 mL of the 
diluted extract was considered the maximum volume that could be brought onto the 
membrane without over soaking the membranes. Over soaking of the membranes 
would impede the flow of solvents through the membrane. Because a 3 mL column 
was used for the GBA, this offered a practical limitation as in general, the 4 mL 
diluted extract should be applied twice (2x2 mL). Larger volumes would imply longer 
assay time. For this reason, a 4 mL portion of diluted sample extract was considered 
optimum for both assays. 
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Gel-based assay 
 
Development of a multiplex screening assay involved first and foremost the 
optimization of different parameters for a single analyte assay. The different anti-
mycotoxin antibodies and mycotoxin−HRP conjugate dilutions developed and 
optimized for single analyte detection were evaluated and reoptimized for multi-
analyte detection. The entire assay development protocol involved the optimization of 
key influential parameters such as the choice of the coupling support, optimization of 
washing solutions and washing volumes and the thickness of the single analyte gel 
layer.  
Choice of the coupling support and indirect coupling approach  
 
Considering the fact that all the GBAs reported in scientific literature only made use 
of CNBr activated Sepharose 4B as coupling support [10, 11, 15, 18 and 28], it was 
deemed necessary to compare another variant of this coupling support such as CNBr 
activated Sepharose 4B Fast Flow, which to the best of our knowledge has not been 
reported in the field of mycotoxin analysis. The CNBr activated Sepharose 4B Fast 
Flow is widely used in chromatographic applications for separation and purification of 
compounds. Both coupling agents have the same average bead diameter (90 µm) but 
differ in the number of cross linkers as well as the antibody coupling capacity. 
Sepharose 4B Fast Flow has a higher number of cross linkers than Sepharose 4B. The 
coupling capacity of the later is twice higher than that of the former. However, since 
only small amounts of rabbit anti-mouse are often recommended for coupling, the 
difference in coupling capacity was not considered as one of the major factors which 
could significantly influence the performances of the different gel types. The nature 
and strength of the cross linkers was however considered as the most influential 
parameter. Both gels were evaluated in parallel experiments while keeping all other 
conditions constant. The results obtained with Sepharose activated 4B Fast Flow were 
more reproducible unlike those obtained with the use of Sepharose 4B. This difference 
could be explained by the high network of cross linkers (lysine residues) within the 
Sepharose 4B Fast Flow gel. The lysine residues interact strongly with other 
electrophilic residues on the coupled rabbit anti-mouse immunoglobulin through 
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molecular interactions such as hydrogen bonds, electrostatic and Van Der Waals 
forces. 
Because of the consistency of the results obtained with Sepharose activated 4B Fast 
Flow, this coupling support was selected as coupling medium. Using control blanks 
and fortified blank samples, all parameters were optimized so as to obtain equal colour 
development in all the four detection layers within 3-7 min following the addition of 
the Colorburst Blue TMB/Peroxide solution. Direct coupling of the respective 
anti−mycotoxin antibody onto these coupling supports gave similar results with the 
indirect coupling approach (first coupling of the rabbit anti-mouse antibody, then the 
anti-mycotoxin antibody). However, much higher concentrations (a factor of 10 or 
more) of these anti−mycotoxin antibodies were required for coupling compared to the 
concentrations used following the indirect coupling approach. The direct approach did 
not improve the overall sensitivity of the assay. Moreover, the use of high 
concentrations of the anti-mycotoxin immunoglobulin could seriously compromise the 
cost-effectiveness of such assays to be used in low-income communities. For this 
reason the direct coupling approach was not further developed. 
Optimization of the washing solution and washing volumes  
PBS with or without additives (casein, Tween 20) was investigated as washing 
solution. Washing with 10 mL PBS and PBS−(0.01%, 0.03%, 0.05%) casein did not 
result in complete removal of the excess mycotoxin−HRP conjugates and as a result 
all assays (blank samples as well as fortified samples) gave very high colour 
intensities. Similarly, large volumes of PBS−0.05%casein solution (30 mL, 40 mL) 
did not improve the performance of this washing solution. Higher percentages of 
casein could not be used because this could lead to an increase in the viscosity of the 
washing solution and thus would greatly compromise its suitability to be used as a 
washing solution. 
Due to the relatively high rigidity of the swollen Sepharose 4B Fast Flow, a stronger 
washing solution or detergent was therefore needed. Tween 20 was preferred to casein 
as additive. The lower viscosity of the PBS−0.05%Tween 20 solution also contributed 
to it been preferred over the PBS−0.05%casein solution. The PBS−0.05%Tween 20 
detergent solution can easily flow-through the highly crossed linked Sepharose 4B 
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Fast Flow assay gel to eliminate excess of the unbound immunoreagents and other 
interfering substances which could affect the performance of the assay. This 
characteristic made it suitable for its purpose. Different percentages of Tween 20 
(0.01%, 0.05%, 0.1%, 0.5% and 1%) in PBS were evaluated. PBS−0.05%Tween 20 
gave very satisfactory results. Higher percentages of Tween 20 (0.1, 0.5 and 1%) in 
PBS were too strong to be used while lower percentages resulted in a high degree of 
false negatives. Finally, washing with 10 mL of PBS−0.05%Tween 20 proved optimal. 
Effect of the thickness of the gel layer on the performance of the GBA 
The use of a 10 mm thick gel resulted in a more rigid gel, which required large 
volumes of washing solution and/or several washing cycles during each of the assay 
steps. Insufficient washing cycles (volumes) resulted to insufficient removal of excess 
of mycotoxin-HRP conjugates and as a result led to unreliable results (higher false 
negative rate due to the persistent blue coloration). An additional problem encountered 
with the use of the 10 mm thick gel was the inhomogeneous distribution of the rabbit 
anti-mouse-anti-mycotoxin antibody coupled conjugate within the specific analyte gel 
layer. However, a 5 mm gel gave excellent and reproducible homogeneous gel layers. 
Thus, 5 mm was chosen as the optimal gel thickness. This was prepared by adding 25 
µL of the coupled gel to 225 µL of the blocked gel.  
Performance characteristics of the GBA 
The assay cut-off limits were determined using the performance characteristic curve as 
described in the mention on method validation. The assay cut−off limits were 3 µg kg-
1
, 1250 µg kg
-1
, 200 µg kg
-1 
and 1000 µg kg
-1 
for OTA, FB1, ZEN and DON 
respectively for the three different food matrices evaluated in this study. These cut−off 
limits were either below or at the maximum levels of these toxins in the different 
matrices evaluated as specified by the European Commission Decision 1187/2007 and 
1881/2006. Especially for the control of exports of food commodities from low 
resource communities, assays with such cut−off limits will allow quick decisions to be 
taken in order to ascertain if the levels in the foodstuffs exceed the maximum 
permitted levels or not. Fig. 2 shows the results obtained with a typical multiplex 
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assay column after screening of a blank sample (column B) and a sample fortified 
above the respective analyte cut-off limits (column A).  
Table 3 shows the qualitative performance characteristics obtained with maize 
samples for ZEN, DON, FB1 and OTA. The results obtained indicated excellent 
specificity (100%) for all four analytes. Furthermore, the assays was more sensitive to 
DON and FB1 (100% sensitivity) and less sensitive to ZEN and OTA (sensitivity 95 
%). The low sensitivity for ZEN and OTA could be attributed to the low cut-off values 
for these analytes, causing fluctuations in the assay procedure to significantly 
influence the outcome of the results. On the other hand the false positive rate was 0% 
for all the analytes. Similarly, a 0% false negative rate was obtained for the analysis of 
DON and FB1 whereas a 5% rate was obtained for ZEN and OTA. The positive 
predictive value was 100% for all the analytes evaluated. On the other hand the 
negative predictive value was 95% for ZEN and OTA and 100% for DON and FB1. 
Similar results were obtained when the other matrices (peanuts, peanut cake and 
cassava flour) were evaluated. This observation further strengthen the fact that the 
different matrix types had little or no influence on the final results. Most probably, the 
influence of the different matrices on the assay result, was completely minimized after 
the sample extract was subjected to the rigorous but simple sample clean-up procedure 
described herein. Consequently, the assumption that the quality (specificity) of the 
immunoreagents used had a much greater influence on the final assay parameters can 
be very well valid for the screening assays reported herein.  
As previously described, the performance characteristic curve was also used to 
determine the uncertainty region for the different analytes. The performance 
characteristic curve for OTA using fortified maize sample is as shown in Fig. 3. The 
shape of this curve could be described as sigmoid. C0 is defined as the concentration at 
the point of intersection of the fitted sigmoid curve and the type 1 error line (αo) while 
C1 is defined as the concentration at the point of intersection of the fitted sigmoid 
curve and the type II error line (βo). The interval C0−C1 represents the uncertainty 
region corresponding to false response rates. This region is specific for each analyte. 
For OTA detection, this region lies between 1.2 to 2.8 µg kg
-1
. The values for the 
uncertainty regions for FB1, DON and ZEN were also computed and are as shown in 
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Table 4. As can be seen the uncertainty range was broader for ZEN, FB1 and DON in 
that order while OTA had the smallest uncertainty range. These differences could be 
attributed to the different properties of the anti-mycotoxin antibodies used to develop 
the multiplex assay. 
 
Membrane-based assay 
Two other membranes types commonly used to bind proteins (Biotrace NT and 
activated PES (ultrabind)), in blotting and dot binding assays were also investigated. 
These membranes did not offer any advantage over the Immunodyne ABC membrane. 
These membranes were less hydrophilic and as a consequence the flow of aqueous 
reagents (buffer solutions) through these membranes was greatly impeded which led to 
an increase in the total assay time (more than 1 h). Moreover, these membranes 
required longer incubation times for protein binding. Due to these shortcomings, both 
membranes were not further investigated. The Immunodyne ABC membrane was 
selected as the membrane of choice. However, different parameters which could 
influence the assay performance such as dilution factor of the sample extract with PBS 
was also evaluated and optimized. 
 
Performance characteristics of the MBA 
As previously described, the assay cut-off limits were determined using the 
performance characteristic curve. The assay cut-offs for the different mycotoxins were 
3 µg kg
-1
, 5 µg kg
-1
, 700 µg kg
-1
and 175 µg kg
-1 
for OTA, AFB1, DON and ZEN 
respectively. These cut-offs were the same for all the matrices evaluated. Fig.4 shows 
the results obtained with the optimized MBA protocol. The top cassette shows the 
results obtained with a control blank (negative) sample while the bottom cassette 
shows the results obtained with a sample spiked at or above the assay cut-off value for 
the different analytes. As illustrated in Fig. 4, no background coloration was observed, 
which is an indication of the good sample preparation protocol. Furthermore, less 
background coloration implied easy interpretation of results, thus eliminating the 
aspect of individual subjectivity in evaluating the results. Table 5 shows the qualitative 
performance characteristics obtained from the validation experiments with maize, for 
all four mycotoxins. The specificity of the MBA was 100% for all the four 
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mycotoxins. Consequently, the probability of obtaining true negatives was 100% 
while the sensitivity was 100% for all four mycotoxins.  
The percentage false negative rate was 0% for all the four mycotoxins, hence 
illustrating the excellent compliance of the assay with the recommendation of 
Commission Decision 2002/657. Finally, the positive and the negative predictive 
value were 100 % for all the analytes evaluated. Similar results were obtained with the 
other sample matrices (peanuts, peanut cake and cassava flour). Based on the excellent 
performance characteristic presented herein, the membrane-based flow-through assay 
could be considered as very reliable to screen for four targeted mycotoxins in four 
variety of food matrices. 
Screening of naturally contaminated samples using the optimized MBA and GBA 
 
In order to evaluate the applicability of both optimized assays, naturally contaminated 
samples were analysed in the laboratory and in the field. Naturally contaminated 
maize, peanuts and cassava flour samples were analyzed in triplicate. Table 6 shows 
the different results obtained with the naturally contaminated samples as well as the 
concentration of the different toxins measured in these contaminated samples 
following LC-MS/MS analysis. FB1, DON and ZEN were not detected in peanut 
samples. Similarly, DON and ZEN were not detected in all the cassava flour samples 
analyzed. All peanut cake samples were contaminated with AFB1 above 5 g kg
-1
 as 
revealed by both the LC-MS/MS and flow-through assays. Four peanut cake and all 
five cassava flour samples were OTA positive above the assays cut-off level (3 g kg-
1
). Results obtained with positive samples gave a very good visual contrast compared 
to those obtained with negative samples. In summary, both flow-through assays 
demonstrated excellent applicability as the results were in accordance with the LC-
MS/MS results. Similarly, both MBA and GBA were field tested under tropical 
conditions in Cameroon, West Africa. A total of 60 (30 maize, 15 peanuts and 15 
cassava flour) ground samples were screened. In summary, FB1 and DON were the 
mycotoxins with a high frequency of occurrence in the maize samples (93% FB1 and 
37% DON). OTA and AFB1 were detected in 67% and 82% respectively of the peanut 
total samples screened while AFB1 was detected in 80% of the cassava flour samples. 
The LC-MS/MS results for these samples and others will be reported in subsequent 
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publications. A false negative rate of 3% was obtained for both tests. The results 
therefore revealed very good compliance of both assay types when used in tropical 
field conditions. However, it should be mentioned that all reagents were kept in ice 
prior to usage. All analyses were performed under the shadow in order to prevent 
protein denaturation by UV rays. The ice box could withhold ice for as long as 12 h 
with no significant increase in the inner temperature of the recipient. Without strict 
implementation of these conditions, the results reported herein would have been 
difficult to obtain in the field. 
Comparison of both MBA and GBA formats 
A successful screening method should be robust, sensitive with a high degree of 
flexibility, over a wide range of compounds. The assay protocol and results should be 
reproducible and the results obtained must be relevant and easy to analyze. For field 
work, the system should also be rapid and portable. Both assay types fulfilled all of the 
above cited criteria. Both assays also showed a much lower false negative rate when 
used under tropical field conditions, thus revealing excellent performance 
characteristics of such assays.  
From a practical point of view, the MBA offers few advantages over the GBA. First 
and foremost, the preparation of the multiplex GBA column involved several steps, 
which if not carefully controlled can lead to serious consequences ranging from no 
signal generation to high false negative or positive rate. On the contrary, with the 
MBA, the assay steps are quite simple to follow from start to finish and did not require 
so much effort and concentration in order to achieve the desired results. Furthermore 
the preparation of the coupling support in the GBA requires approximately 6 h of 
laboratory time, unlike with the MBA whereby preparation of the assay membrane 
requires only 1 h of laboratory time, but can also be carried out under non laboratory 
conditions, which thus supports the applicability of such assay in low-income 
communities.  
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Conclusions  
Two flow-through enzyme immunoassay formats for the detection of four mycotoxins 
in peanut cake, maize and cassava flour samples were successfully developed. Both 
assays did not make use of any equipment and consisted of limited operational steps, 
providing a yes/no response indicating whether the toxins were present or not above 
the maximum permitted levels of these analytes in the different matrices. Coupled to a 
simple and fast sample pretreatment the present approach allows to eliminate 
“compliant” samples from the sample set and helps prioritizing the “non-compliant” 
ones. Though these assays were originally developed for maize, peanut cake and 
cassava, other sample matrices such as unprocessed peanuts also gave very 
satisfactory results. Other sample matrices such as cornflakes and bread are also under 
investigation. 
 
A regional experts meeting in 2006 on the mycotoxin problem with particular 
reference to resource limited communities reiterated the need for efficient, cost-
effective analytical methods that can be used for the detection of mycotoxins in low-
income communities [29]. Consequently, the availability of such multiplex assays for 
the screening of mycotoxins in a variety of food matrices may lead to safer consumer 
products in future, especially in low-income communities. 
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Table 1  
Percentage of each of the five mycotoxins trapped during different sample treatments 
 
Percentage of mycotoxin trapped (%)±SD 
a
Mycotoxins membrane filter  
(n=3) 
custom made C18 SPE catridge 
(n=3) 
AFB1 0 ±0 20 ±0.5 
DON 3 ±0.1 7 ±0.7 
OTA 5.4 ±0.1 13 ±1 
ZEN 0 ±0 6 ±0.4 
FB1 2.5 ±0.3 9 ±0.7 
a
spiked concentrations: AFB1, 10 µg kg
-1
; DON, 1000 µg kg
-1
; OTA, 3 µg kg
-1
; ZEN, 200 µg kg
-1
 and FB1, 1250 µg kg
-1  
SD: standard deviation 
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Table 2  
Recovery data for the four different analytes using three different volumes of extraction solvent. Same extraction procedure was used for MBA 
and GBA. 
 
 Recovery (%)±SD 
Mycotoxins Maize Peanut cake Cassava flour 
 EV1 EV2 EV3 EV1 EV2 EV3 EV1 EV2 EV3 
AFB1 54±1 90±8 96 ± 59±1 72±11 79±6 61±11 75±4 89±3 
DON 60±4 79±6 88 ±7 51±7 65±3 73±4 59±5 68±0.1 75±8 
OTA 47±2 90±18 107 ±8 48±7 61±6 71±16 54±7 66±17 82±7 
ZEN 50±9 68±1 91 ±10  56±13 70±3 82±5 51±6 72±6 88±2 
FB1 57±3 81±4 95 ±4 41±6 51±8 76±5 38±2 63±2 71±9 
 
SD: standard deviation. EV: extraction volume 
EV1: 2.5 mL, EV2:5 mL, EV3:10 mL 
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Table 3 
Summarized performance characteristics for the GBA obtained with maize samples 
a
Performance parameters 
b
Mycotoxins 
(%) ZEN DON FB1 OTA 
False positive rate 0 0 0 0 
False negative rate 5 0 0 5 
Sensitivity 95 100 100 95 
Specificity 100 100 100 100 
Positive predictive value 100 100 100 100 
Negative predictive value 95 100 100 95 
a40 samples were used to determine the performance characteristics: 20 control blank samples and 20 samples 
fortified at the assay cut-off limits for the different analytes. 
bspiked level: 3 µg kg-1, 1250 µg kg-1, 200 µg kg-1 and 1000 µg kg-1 for OTA, FB1, ZEN and DON respectively  
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Table 4 
The uncertainty regions for FB1, DON, OTA and ZEN obtained with the GBA 
 
Uncertainty level (µg kg
-1
) Mycotoxins 
 FB1 DON OTA ZEN 
C0  400 250 1.2 100 
C1 900 900 2.8 177 
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Table 5 
Summarized performance characteristics for the MBA obtained with maize samples  
 
a
Performance parameters 
(%) 
Mycotoxins 
AFB1 DON OTA ZEN 
False positive rate 0  0 0  0 
False negative rate 0  0 0 0 
Sensitivity 100  100 100 100 
Specificity 100  100 100 100 
Positive predictive value 100  100 100 100 
Negative predictive value 100  100 100 100 
a40 samples were used to determine the performance characteristics: 20 control blank samples and 20 samples 
fortified at the assay cut-off limits for the different analytes. 
bspiked level: 3 µg kg-1, 5 µg kg-1, 700 µg kg-1and 175 µg kg-1 for OTA, AFB1, DON and ZEN respectively  
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Table 6 
 
Results obtained after screening (gel-based assay (GBA) and membrane based assay (MBA)) and confirmatory analysis (LC-MS/MS) of 
naturally contaminated samples  
 
Sample 
matrices 
Visual results
a
: 
GBA
b
  
Visual results
a
:  
MBA
c
 
LC-MS/MS results 
(µg kg
-1
) 
 FB1 DON ZEN OTA AFB1 DON ZEN OTA AFB1 FB1 DON ZEN OTA 
Maize 1 
Maize 2 
Maize 3 
Maize 4 
Maize 5 
- - + - - + - - <LOQ 305 705 186 nd 
+ - - - - + - - nd 2623 990 50 nd 
+ + + - - + + - <LOQ 3258 2197 297 nd 
- - + - - - + - <LOQ 1056 416 187 nd 
+ + + - - + + - nd 2156 1360 315 nd 
Peanut cake 1 
Peanut cake 2 
Peanut cake 3 
Peanut cake 4 
Peanut cake 5 
- - - + + - - + 292 nd nd nd 4 
- - - + + - - + 189 nd nd nd 3.7 
- - - + + - - - 154 nd nd nd 2 
- - - + + - - + 120 nd nd nd 3.6 
- - - + + - - + 340 nd nd nd 15 
Cassava 1 
Cassava 2 
Cassava 3 
Cassava 4 
Cassava 5 
- - - + + - - + 58 nd nd nd 3 
- - - + + - - + 90 <LOQ nd nd 9 
- - - + + - - + 160 nd nd nd 20 
- - - + + - - + 41 <LOQ nd nd 12 
- - - + + - - + 86 nd nd nd 6 
nd: not detected, LOQ: limit of quantification 
+: analyte concentration≥cut-off limit, -: analyte concentration<cut-off limit. 
aall experiments were realized in triplicate 
bGBA cut−off limits: 3 µg kg-1, 1250 µg kg-1, 200 µg kg-1 and 1000 µg kg-1 for OTA, FB1, ZEN and DON respectively 
cMBA cut-off limits: 3 µg kg-1, 5 µg kg-1, 175 µg kg-1 and 700 µg kg-1 for OTA, AFB1, ZEN and DON respectively 
 
 
 
 36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1,  
 
 
 
 
 
 
 
 
 
 
 
 
a b 
d c 
 37 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test layers for; a:OTA, b:DON, c:FB1, d:ZEN  
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Fig 3  
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Figure captions 
Fig. 1:  
(a) Schematic representation of a typical gel-based multiplex assay column, (b) Design of 
prepared assay membrane, (c) Top and bottom components of a typical cassette used 
for MBA, (d) Cassette filled with absorbent pads, on top of which is placed the assay 
membrane. 
 
Fig. 2:  
Results obtained with a multiplex GBA column after analysis of a blank sample (column 
B) and a positive sample (column A) contaminated with the four analytes above the assay 
cut-offs. 
 
Fig. 3:  
The performance characteristic curve for OTA as obtained with the GBA 
Fig. 4:  
Visual results with MBA assay conditions following analysis of a blank and spiked 
samples. Top figure: control blank; bottom figure: test sample spiked at the assay cut-off 
limit for the different analytes. 
 
 
 
 
 
 
